Format

Send to

Choose Destination
Blood. 2014 Nov 20;124(22):3330-2. doi: 10.1182/blood-2014-09-598995.

KIR3DL2 is a coinhibitory receptor on Sézary syndrome malignant T cells that promotes resistance to activation-induced cell death.

Author information

1
Institut National de la Santé et de la Recherche Médicale U976, Onco-Dermatology, Immunology and Cutaneous Stem Cells, Paris, France University Paris Diderot, Sorbonne Paris Cité, Paris, France.
2
Institut National de la Santé et de la Recherche Médicale U976, Onco-Dermatology, Immunology and Cutaneous Stem Cells, Paris, France Immunology Service, University Hospital Virgen de la Arrixaca, El Palmar, Murcia, Spain.
3
Institut National de la Santé et de la Recherche Médicale U976, Onco-Dermatology, Immunology and Cutaneous Stem Cells, Paris, France University Paris Diderot, Sorbonne Paris Cité, Paris, France Assistance Publique-Hôpitaux de Paris, Saint Louis Hospital, Department of Dermatology, Paris, France.
PMID:
25414436
DOI:
10.1182/blood-2014-09-598995
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center